Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Societal CDMO, Inc. - Common Stock
(NQ:
SCTL
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Apr 5, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Societal CDMO, Inc. - Common Stock
< Previous
1
2
3
Next >
12 Health Care Stocks Moving In Monday's Pre-Market Session
August 28, 2023
Via
Benzinga
Crude Oil Edges Lower; Dollar Tree Earnings Top Estimates
August 24, 2023
U.S. stocks traded lower toward the end of trading, with the Dow Jones falling around 250 points on Thursday. The Dow traded down 0.75% to 34,212.95 while the NASDAQ fell 1.11% to 13,568.87. The S&P...
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
12 Health Care Stocks Moving In Thursday's Intraday Session
August 24, 2023
Via
Benzinga
US Stocks Turn Lower; Nasdaq Down Over 1%
August 24, 2023
U.S. stocks turned lower midway through trading, with the Dow Jones falling more than 200 points on Thursday. The Dow traded down 0.60% to 34,265.04 while the NASDAQ fell 1.35% to 13,535.36. The S&P...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
A Preview Of Societal CDMO's Earnings
August 11, 2023
Via
Benzinga
Societal CDMO's Earnings Outlook
August 08, 2023
Via
Benzinga
Societal CDMO: Q1 Earnings Insights
May 10, 2023
Via
Benzinga
Earnings Scheduled For March 1, 2023
March 01, 2023
Companies Reporting Before The Bell • Globalstar (AMEX:GSAT) is expected to report quarterly loss at $0.01 per share on revenue of $38.75 million.
Via
Benzinga
Societal CDMO Earnings Preview
February 28, 2023
Via
Benzinga
Why Splunk Are Trading Higher By 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
August 24, 2023
Gainers Electriq Power Holdings, Inc. (NYSE: ELIQ) shares jumped 130.3% to $3.3847.
Via
Benzinga
Dow Jumps 150 Points; NVIDIA Tops Q2 Views
August 24, 2023
U.S. stocks traded higher this morning, with the Dow Jones gaining more than 150 points on Thursday. Following the market opening Thursday, the Dow traded up 0.48% to 34,638.62 while the NASDAQ rose...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Thursday's Pre-Market Session
August 24, 2023
Via
Benzinga
Societal CDMO's Return On Capital Employed Insights
December 14, 2022
Via
Benzinga
Why Opera Shares Are Trading Lower By Around 12%; Here Are 20 Stocks Moving Premarket
August 24, 2023
Gainers Bruush Oral Care Inc. (NASDAQ: BRSH) shares gained 45.1% to $2.51 in pre-market trading after falling 50% on Wednesday.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
August 23, 2023
Via
Benzinga
Psyched: Fed Study On Psychedelics, Janet Yellen's Magic Mushrooms, Financing Deals & Quarterly Reports
August 21, 2023
Cannabis, Psychedelics Use And Binge Drinking At All-Time High Among Adults, Teens Remain Stable, Fed Study Finds
Via
Benzinga
Topics
Cannabis
Economy
Exposures
Cannabis
Interest Rates
$21.8M Revenue For NASDAQ-Listed Psychedelics Ancillary Company Societal CDMO's Q2 2023
August 16, 2023
Societal CDMO Inc. (NASDAQ: SCTL), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manufacturing challenges for small molecule therapeutics,...
Via
Benzinga
Earnings Scheduled For August 14, 2023
August 14, 2023
Companies Reporting Before The Bell • Safe & Green Holdings (NASDAQ:SGBX) is likely to report quarterly loss at $0.23 per share on revenue of $6.88 million.
Via
Benzinga
Psyched: Portugal Decriminalizes Synthetic Drugs, Anorexia And Psilocybin, LSD Microdosing, California & More
August 03, 2023
A Revolutionary Approach: Portugal Decriminalizes Synthetic Drugs Portugal’s Parliament recently decriminalized the use of synthetic drugs. The new law equates the legal treatment of these substances...
Via
Benzinga
Innovator Embraces Psychedelic Horizons With New Schedule 1 Manufacturing License
July 27, 2023
A new player is entering the psychedelics production space.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
June 07, 2023
Via
Benzinga
Why Inovio Pharmaceuticals Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket
May 24, 2023
Gainers Minerva Surgical, Inc. (NASDAQ: UTRS) shares rose 202.3% to $0.5499 in pre-market trading. Minerva Surgical was granted U.S. Patent #11653972 for "Medical Systems And Methods (For Resecting And...
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
May 24, 2023
It's time for a dive into the biggest pre-market stock movers as we check out all of the latest news for Wednesday morning!
Via
InvestorPlace
Cingulate Announces Successful Transfer of CTx-1301 (dexmethylphenidate) Proprietary PTR™ Manufacturing Processes to Societal CDMO
May 03, 2023
Scalable Supply of CTx-1301 Ready to be Produced with Cingulate on Track to Meet Previously Announced Clinical Timelines for Phase 3 Trial Program
From
Cingulate Inc.
Via
GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For March 24, 2023
March 24, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
March 02, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
December 12, 2022
Via
Benzinga
A Preview Of Societal CDMO's Earnings
November 08, 2022
Societal CDMO (NASDAQ:SCTL) is set to give its latest quarterly earnings report on Wednesday, 2022-11-09. Here's what investors need to know before the announcement. Analysts estimate that Societal...
Via
Benzinga
Cingulate Shares Fall After Timeline Update For Its Lead Candidate In ADHD
October 25, 2022
Cingulate Inc (NASDAQ: CING) is preparing to initiate a Phase 3 adult dose-optimization study later this year for its lead candidate, CTx-1301, to assess the onset and duration of efficacy and safety...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
August 16, 2022
Via
Benzinga
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.